Chengla Yi

Prof. Chengla Yi


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2022 in Contrast Media & Molecular Imaging
Verified
Journal Article
Open access
PDF file
YZYingchi Zhang
Yingchi Zhang
RLRui Lu
Rui Lu
HXHuang XiaoJian
Huang XiaoJian
EYEnzhi Yin
Enzhi Yin
YYYong Yang
Yong Yang
XYXuefeng Yuan
Xuefeng Yuan
Osteoarthritis (OA) is a rheumatic disease and its pathogenesis involves the dysregulation of noncoding RNAs. Therefore, the regulatory mechanism of circular RNA MELK (circMELK) was specified in this work. OA human cartilage tissue was collected, and circMELK, miR‐497‐5p, and myeloid differentiation factor 88 (MYD88) expression were examined. Human chondrocytes were stimulated with interleukin‐ (IL‐) 1β and interfered with vectors altering circMELK, miR‐497‐5p, and MyD88 expression to observe their effects on cell viability, cell cycle and apoptosis, autophagy, and inflammation. The binding relationship between RNAs was verified. The data presented that OA cartilage tissues presented raised circMELK and MYD88 and inhibited miR‐497‐5p expression. IL‐1β suppressed cell viability, prevented cell cycle, and induced apoptosis, autophagy, and inflammation of chondrocytes. Functionally, IL‐1β‐induced changes of chondrocytes could be attenuated by suppressing circMELK or overexpressing miR‐497‐5p. circMELK acted as a sponge of miR‐497‐5p while miR‐497‐5p was a regulator of MYD88. MYD88 restricted the effect of overexpressing miR‐497‐5p on IL‐1β‐stimulated chondrocytes. MYD88 triggered nuclear factor‐kappaB (NF‐κB) pathway activation. Shortly, CircMELK promotes chondrocyte apoptosis and inhibits autophagy in OA by regulating MYD88/NF‐κB signaling axis through miR‐497‐5p. Our study proposes a new molecular mechanism for the development of OA.

19 April 2017 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
XZXin-Yu Zhou
Xin-Yu Zhou
DHDian Xing Hu
Dian Xing Hu
RCRuo Qiao Chen
Ruo Qiao Chen
XCXiao Qian Chen
Xiao Qian Chen
WDWanli Dong
Wanli Dong
CYChengla Yi
Chengla Yi

1 April 2020 in Inflammation
Verified
Journal Article
Closed access
PDF file
TLTianyu Li
Tianyu Li
QLQiang Luo
Qiang Luo
LHLi He
Li He
DLDa Li
Da Li
QLQingnian Li
Qingnian Li
CYChengla Yi
Chengla Yi

1 September 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
TLTao Liu
Tao Liu
CXChen-Chen Xue
Chen-Chen Xue
YSYu-Long Shi
Yu-Long Shi
XBXiang-Jun Bai
Xiang-Jun Bai
ZLZhan-Fei Li
Zhan-Fei Li
CYChengla Yi
Chengla Yi

1 February 2017 in Neuroscience Letters
Verified
Journal Article
Closed access
YSYulong Shi
Yulong Shi
CYChengla Yi
Chengla Yi
XLXiao Li
Xiao Li
JWJiangpeng Wang
Jiangpeng Wang
FZFangyuan Zhou
Fangyuan Zhou
XCXiaoqian Chen
Xiaoqian Chen

1 June 2016 in Chinese Journal of Traumatology
Verified
Journal Article
Open access
XLXiao-Yuan Liu
Xiao-Yuan Liu
MJMeng Jiang
Meng Jiang
CYChengla Yi
Chengla Yi
XBXiang-Jun Bai
Xiang-Jun Bai
DHDavid J. Hak
David J. Hak
Early intramedullary nailing (IMN) within the first 24 h for multiply injured patients with femoral fracture and concomitant thoracic trauma is controversial. Previously published studies have been limited in size and their outcomes have been inconclusive. A meta-analysis was conducted to evaluate the available data in order to guide care and help improve the outcomes for these patients. We searched the literature up to December 2011 in the main medical search engines and identified 6 retrospective cohort studies that explored the safety of early IMN in patients with both femoral fracture and chest injury. Our primary outcome was the rates of pulmonary complication (pneumonia, adult respiratory distress syndrome, fat embolism syndrome), multiple organ failure (MOF) and mortality. We found no statistically significant difference in the rate of pulmonary complications, MOF or mortality in the patients treated with early IMN. Early IMN for femoral fractures does not increase the mortality and morbidity in chest-injured patients in the studies analyzed.